Showing results (721-730 of 2,193) with videos related to

Sort By:
Pageof 220
Neurotoxicity Research|April 23, 2009
Histaminergic activity in a rodent model of Parkinson's diseasePrzemysław Nowak, Lukasz Noras, Jerzy Jochem, et al.
Neurotoxicity Research|July 18, 2009
Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30Shunit Gal, Hailin Zheng, Mati Fridkin, et al.
Neurotoxicity Research|July 18, 2009
Endogenous zinc mediates apoptotic programmed cell death in the developing brainEunsil Cho, Jung-Jin Hwang, Seung-Hee Han, et al.
Neurotoxicity Research|August 25, 2009
Genetic susceptibility in solvent induced neurobehavioral effectsL Godderis, N Maertens, V de Gelder, et al.
Neurotoxicity Research|February 10, 2010
Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamineNathalie Thiriet, Benjamin Gennequin, Virginie Lardeux, et al.
Neurotoxicity Research|December 24, 2005
Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degenerationNorbert Babai, Tamás Atlasz, Andrea Tamás, et al.
Neurotoxicity Research|February 20, 2010
Hippocampal neurons exposed to the environmental contaminants methylmercury and polychlorinated biphenyls undergo cell death via parallel activation of calpains and lysosomal proteasesRoshan Tofighi, Carolina Johansson, Matteo Goldoni, et al.
Neurotoxicity Research|August 28, 2016
Maternal Exposure to Valproic Acid Primarily Targets Interneurons Followed by Late Effects on Neurogenesis in the Hippocampal Dentate Gyrus in Rat OffspringYousuke Watanabe, Tomoaki Murakami, Masashi Kawashima, et al.
Neurotoxicity Research|September 16, 2016
Caffeine Induces a Stimulant Effect and Increases Dopamine Release in the Nucleus Accumbens Shell Through the Pulmonary Inhalation Route of Administration in RatsMartín Galvalisi, José Pedro Prieto, Marcela Martínez, et al.
Neurotoxicity Research|May 21, 2017
Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-SerineWalter G Bradley, R X Miller, T D Levine, et al.
Pageof 220